Cell Therapy Market - Global Professional Analysis and Forecast to 2026

Nov 07, 2019 | 169 PAGES | REPORT CODE: CMM230389

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

The worldwide Cell Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.3% during the forecast period.

This report presents the market size and development trends by detailing the Cell Therapy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cell Therapy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cell Therapy industry and will help you to build a panoramic view of the industrial development.

Cell Therapy Market, By Type:

Induced pluripotent stem cells (iPSCs)
Bone marrow
Umbilical cord blood-derived cells
Adipose tissue
Neural stem cell

Cell Therapy Market, By Application:

Hospital & clinics
Regenerative medicine centers
Diagnostic centers
Research institutes
Others

Some of the leading players are as follows:

Cognate
Osiris
Genzyme Corporation
Cynata
Pluristem
GlaxoSmithKline plc
Advanced Tissue
EUFETS GmbH
MEDIPOST
NuVasive, Inc.
JCR Pharmaceuticals Co., Ltd
BioNTech IMFS
Grupo Praxis
ANTEROGEN.CO.,LTD.
CELLECTIS
Novartis AG
PHARMICELL

Geographically, Major regions are analyzed in details are as follows:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Table of Contents

1 Methodology and Scope

1.1 Market Segmentation & Scope

1.1.1 Technology Type
1.1.2 Product
1.1.3 Application
1.1.4 Regional scope
1.1.5 Estimates and forecast timeline

1.2 Research Methodology
1.3 Information Procurement

1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research

1.4 Information or Data Analysis

1.4.1 Data analysis models

1.5 Market Formulation & Validation
1.6 Model Details

1.6.1 Commodity flow analysis
1.6.2 Volume price analysis

1.7 List of Secondary Sources
1.8 List of Abbreviations

2 Executive Summary

2.1 Market Outlook
2.2 Segment Outlook

3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.1.1 Parent market outlook

3.1.2 Ancillary market outlook

3.2 Market Segmentation

3.2.1 Analysis

3.3 Market Dynamics

3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3 Industry opportunities

3.4 Penetration & Growth Prospect Mapping

3.4.1 Penetration & growth prospect mapping analysis

3.5 Business Environment Analysis Tools

3.5.1 Porter's five forces analysis
3.5.2 PESTLE analysis
3.5.3 Major deals & strategic alliances analysis

4 Cell Therapy Market: Technology Type Analysis

4.1 Cell Therapy Technology Type Market Share Analysis, 2018 & 2026
4.2 Cell Therapy Technology Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

4.3.1 Induced pluripotent stem cells (iPSCs)
4.3.2 Bone marrow
4.3.3 Umbilical cord blood-derived cells
4.3.4 Adipose tissue
4.3.5 Neural stem cell

5 Cell Therapy Market: Product Analysis

5.1 Cell Therapy Product Market Share Analysis, 2018 & 2026
5.2 Cell Therapy Product Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Cell Therapy Market: Application Analysis

6.1 Cell Therapy Application Market Share Analysis, 2018 & 2026
6.2 Cell Therapy Application Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

6.3.1 Hospital & clinics
6.3.2 Regenerative medicine centers
6.3.3 Diagnostic centers
6.3.4 Research institutes
6.3.5 Others

7 Cell Therapy Market: Regional Analysis

7.1 Cell Therapy Regional Market Share Analysis, 2018 & 2026
7.2 Cell Therapy Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
7.4 List of Players at Regional Level

7.4.1 North America
7.4.2 Europe
7.4.3 Asia Pacific

7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA

7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

7.6.1 North America
7.6.2 Europe
7.6.3 Asia Pacific
7.6.4 Latin America
7.6.5 Middle East & Africa

8 Competitive Analysis

8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3 Vendor Landscape

8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

9.1 Cognate

9.1.1 Cognate Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis

9.2 Osiris

9.2.1 Osiris Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis

9.3 Genzyme Corporation

9.3.1 Genzyme Corporation Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis

9.4 Cynata

9.4.1 Cynata Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis

9.5 Pluristem

9.5.1 Pluristem Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis

9.6 GlaxoSmithKline plc

9.6.1 GlaxoSmithKline plc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis

9.7 Advanced Tissue

9.7.1 Advanced Tissue Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis

9.8 EUFETS GmbH

9.8.1 EUFETS GmbH Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis

9.9 MEDIPOST

9.9.1 MEDIPOST Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis

9.10 NuVasive, Inc.

9.10.1 NuVasive, Inc. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis

9.11 JCR Pharmaceuticals Co., Ltd

9.11.1 JCR Pharmaceuticals Co., Ltd Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis

9.12 BioNTech IMFS

9.12.1 BioNTech IMFS Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis

9.13 Grupo Praxis

9.13.1 Grupo Praxis Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis

9.14 ANTEROGEN.CO.,LTD.

9.14.1 ANTEROGEN.CO.,LTD. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis

9.15 CELLECTIS

9.15.1 CELLECTIS Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis

9.16 Novartis AG

9.16.1 Novartis AG Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis

9.17 PHARMICELL

9.17.1 PHARMICELL Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis

The List of Tables and Figures (Totals 81 Figures and 128 Tables)

Figure Induced pluripotent stem cells (iPSCs) Cell Therapy market, 2015 - 2026 (USD Million)
Figure Bone marrow Cell Therapy market, 2015 - 2026 (USD Million)
Figure Umbilical cord blood-derived cells Cell Therapy market, 2015 - 2026 (USD Million)
Figure Adipose tissue Cell Therapy market, 2015 - 2026 (USD Million)
Figure Neural stem cell Cell Therapy market, 2015 - 2026 (USD Million)
Figure Hospital & clinics market, 2015 - 2026 (USD Million)
Figure Regenerative medicine centers market, 2015 - 2026 (USD Million)
Figure Diagnostic centers market, 2015 - 2026 (USD Million)
Figure Research institutes market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
Table List of players in North America
Table List of players in Europe
Table List of players in Asia Pacific
Table SWOT analysis
Table North America Cell Therapy market, by country, 2015 - 2026 (USD Million)
Table North America Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table North America Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table North America Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.S. Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table U.S. Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table U.S. Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Canada Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Canada Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Canada Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Europe Cell Therapy market, by country, 2015 - 2026 (USD Million)
Table Europe Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Europe Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Europe Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table U.K. Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table U.K. Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table U.K. Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Germany Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Germany Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Germany Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table France Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table France Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table France Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Italy Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Italy Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Italy Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Spain Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Spain Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Spain Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Asia Pacific Cell Therapy market, by country, 2015 - 2026 (USD Million)
Table Asia Pacific Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Asia Pacific Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Asia Pacific Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table China Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table China Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table China Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Japan Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Japan Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Japan Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table India Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table India Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table India Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Latin America Cell Therapy market, by country, 2015 - 2026 (USD Million)
Table Latin America Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Latin America Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Latin America Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Brazil Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Brazil Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Brazil Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Mexico Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Mexico Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Mexico Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Argentina Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Argentina Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Argentina Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table MEA Cell Therapy market, by country, 2015 - 2026 (USD Million)
Table MEA Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table MEA Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table MEA Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table South Africa Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table South Africa Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table South Africa Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Regulatory scenario
Table Nigeria Cell Therapy market, by type, 2015 - 2026 (USD Million)
Table Nigeria Cell Therapy market, by product, 2015 - 2026 (USD Million)
Table Nigeria Cell Therapy market, by application, 2015 - 2026 (USD Million)
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Recent Developments & Impact Analysis, by Key Market Participants
Table Company market position analysis
Table Company Profiles
Table Cognate Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Osiris Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genzyme Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cynata Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pluristem Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advanced Tissue Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table EUFETS GmbH Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table MEDIPOST Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NuVasive, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table JCR Pharmaceuticals Co., Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioNTech IMFS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Grupo Praxis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ANTEROGEN.CO.,LTD. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CELLECTIS Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PHARMICELL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis

REPORTS

Let’s Pullulate and Expand Your Business

Cell Therapy Market - Global Professional Analysis and Forecast to 2026

Report Purchase

REPORTS

Let’s Pullulate and Expand Your Business

Cell Therapy Market - Global Professional Analysis and Forecast to 2026

Report Purchase

Important: Our Responding for the COVID-19Ｘ